Company registration number SC839269 (Scotland)
VM SURGICAL CARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
VM SURGICAL CARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
VM SURGICAL CARE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 1 -
2026
Notes
£
£
Fixed assets
Tangible assets
3
1,208
Current assets
Debtors
4
8,312
Cash at bank and in hand
6,130
14,442
Creditors: amounts falling due within one year
5
(4,099)
Net current assets
10,343
Total assets less current liabilities
11,551
Creditors: amounts falling due after more than one year
6
(579)
Provisions for liabilities
(230)
Net assets
10,742
Capital and reserves
Called up share capital
100
Profit and loss reserves
10,642
Total equity
10,742

For the financial period ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 29 September 2026 and are signed on its behalf by:
Mr V Manda
Director
Company registration number SC839269 (Scotland)
VM SURGICAL CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2026
- 2 -
1
Accounting policies
Company information

VM Surgical Care Limited is a private company limited by shares incorporated in Scotland. The registered office is 2 Arnprior Place, Ayr, South Ayrshire, United Kingdom, KA7 4PT.

1.1
Reporting period

The reporting period ran for a length of 1 year and 34 days, due to this being the company's first year.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.3
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.4
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
33.33% Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

VM SURGICAL CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 3 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

VM SURGICAL CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2026
- 4 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2026
Number
Total
2
3
Tangible fixed assets
Computers
£
Cost
At 26 February 2025
-
0
Additions
1,279
At 31 March 2026
1,279
Depreciation and impairment
At 26 February 2025
-
0
Depreciation charged in the period
71
At 31 March 2026
71
Carrying amount
At 31 March 2026
1,208
4
Debtors
2026
Amounts falling due within one year:
£
Trade debtors
2
Other debtors
8,310
8,312
5
Creditors: amounts falling due within one year
2026
£
Bank loans
632
Corporation tax
2,267
Other creditors
1,200
4,099
VM SURGICAL CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2026
- 5 -
6
Creditors: amounts falling due after more than one year
2026
£
Bank loans and overdrafts
579
7
Directors' transactions

Included within debtors is an amount of £5,977 owed by the directors to the company. No interest has been charged and there are no repayment terms set.

2026-03-312025-02-26falsefalsefalse29 September 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr V MandaDr M MandaSC8392692025-02-262026-03-31SC8392692026-03-31SC839269core:ComputerEquipment2026-03-31SC839269core:CurrentFinancialInstrumentscore:WithinOneYear2026-03-31SC839269core:WithinOneYear2026-03-31SC839269core:AfterOneYear2026-03-31SC839269core:CurrentFinancialInstruments2026-03-31SC839269core:ShareCapital2026-03-31SC839269core:RetainedEarningsAccumulatedLosses2026-03-31SC839269bus:Director12025-02-262026-03-31SC839269core:ComputerEquipment2025-02-262026-03-31SC839269core:ComputerEquipment2025-02-25SC839269core:Non-currentFinancialInstruments2026-03-31SC839269bus:PrivateLimitedCompanyLtd2025-02-262026-03-31SC839269bus:SmallCompaniesRegimeForAccounts2025-02-262026-03-31SC839269bus:FRS1022025-02-262026-03-31SC839269bus:AuditExemptWithAccountantsReport2025-02-262026-03-31SC839269bus:Director22025-02-262026-03-31SC839269bus:FullAccounts2025-02-262026-03-31xbrli:purexbrli:sharesiso4217:GBP